Altria Group, Inc. (MO)

In the Bull scenario, adult consumer discretionary income recovers, curtailing discount trade-down. Regulatory enforcement against illicit disposable vapes redirects nicotine volume back into Marlboro and authorized oral nicotine pouches. Helix's national rollout of on! PLUS across 120,000 stores scales rapidly, turning the smoke-free segment into an accretive profit driver. Altria's FCF generation comfortably supports annual dividend increases and >$1B in annual share repurchases, justifying valuation near the top of the fair value range ($84.57).

• Combustible cigarette volume declines moderate significantly from historical contraction rates.
• Marlboro maintains dominant premium category share while sustaining strong annual pricing realization.
• Modern oral products on! and on! PLUS capture expanding share of the nicotine pouch market.
• FDA PMTA enforcement successfully eliminates illicit disposable vapes from retail shelves
• Consolidated operating margin expands through smokeable pricing realization and supply chain efficiency.
• Annual earnings per share growth accelerates above historical trend lines driven by share repurchases and margin expansion.